Cargando…

Willingness to Pay for COVID-19 Vaccines in Japan

More than 80% of the Japanese population had received the coronavirus disease 2019 (COVID-19) vaccination by the end of April 2023; however, this vaccination rate continues to decline along with the need for booster shots. Further, the vaccines may not permanently be available free of charge. This s...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoda, Takeshi, Iwasaki, Nagisa, Katsuyama, Hironobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671273/
https://www.ncbi.nlm.nih.gov/pubmed/37998275
http://dx.doi.org/10.3390/ijerph20227044
_version_ 1785140115506462720
author Yoda, Takeshi
Iwasaki, Nagisa
Katsuyama, Hironobu
author_facet Yoda, Takeshi
Iwasaki, Nagisa
Katsuyama, Hironobu
author_sort Yoda, Takeshi
collection PubMed
description More than 80% of the Japanese population had received the coronavirus disease 2019 (COVID-19) vaccination by the end of April 2023; however, this vaccination rate continues to decline along with the need for booster shots. Further, the vaccines may not permanently be available free of charge. This study conducted a survey to determine the public’s willingness to pay for the COVID-19 vaccine in Japan. Using an internet research panel, the questionnaire collected data on various sociodemographic variables and the respondents’ willingness to pay for COVID-19 vaccines. Descriptive statistics and logistic regression analysis were used to evaluate the respondents’ answers. The results showed that of 1100 respondents, 55.2% would not want to receive the vaccine if it was paid for. A total of 44.8% respondents expressed willingness to pay, with most (170 respondents) willing to pay for 1000–1999 JPY (7.1–14.2 USD). Logistic regression analysis revealed that age, educational status, history of contracting COVID-19, and COVID-19 vaccination frequency were significantly associated with those who were willing to receive the COVID-19 vaccine if it was free (p < 0.05). These findings provide valuable insights for the Japanese government in determining appropriate pricing strategies to promote COVID-19 vaccination effectively.
format Online
Article
Text
id pubmed-10671273
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106712732023-11-09 Willingness to Pay for COVID-19 Vaccines in Japan Yoda, Takeshi Iwasaki, Nagisa Katsuyama, Hironobu Int J Environ Res Public Health Article More than 80% of the Japanese population had received the coronavirus disease 2019 (COVID-19) vaccination by the end of April 2023; however, this vaccination rate continues to decline along with the need for booster shots. Further, the vaccines may not permanently be available free of charge. This study conducted a survey to determine the public’s willingness to pay for the COVID-19 vaccine in Japan. Using an internet research panel, the questionnaire collected data on various sociodemographic variables and the respondents’ willingness to pay for COVID-19 vaccines. Descriptive statistics and logistic regression analysis were used to evaluate the respondents’ answers. The results showed that of 1100 respondents, 55.2% would not want to receive the vaccine if it was paid for. A total of 44.8% respondents expressed willingness to pay, with most (170 respondents) willing to pay for 1000–1999 JPY (7.1–14.2 USD). Logistic regression analysis revealed that age, educational status, history of contracting COVID-19, and COVID-19 vaccination frequency were significantly associated with those who were willing to receive the COVID-19 vaccine if it was free (p < 0.05). These findings provide valuable insights for the Japanese government in determining appropriate pricing strategies to promote COVID-19 vaccination effectively. MDPI 2023-11-09 /pmc/articles/PMC10671273/ /pubmed/37998275 http://dx.doi.org/10.3390/ijerph20227044 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yoda, Takeshi
Iwasaki, Nagisa
Katsuyama, Hironobu
Willingness to Pay for COVID-19 Vaccines in Japan
title Willingness to Pay for COVID-19 Vaccines in Japan
title_full Willingness to Pay for COVID-19 Vaccines in Japan
title_fullStr Willingness to Pay for COVID-19 Vaccines in Japan
title_full_unstemmed Willingness to Pay for COVID-19 Vaccines in Japan
title_short Willingness to Pay for COVID-19 Vaccines in Japan
title_sort willingness to pay for covid-19 vaccines in japan
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671273/
https://www.ncbi.nlm.nih.gov/pubmed/37998275
http://dx.doi.org/10.3390/ijerph20227044
work_keys_str_mv AT yodatakeshi willingnesstopayforcovid19vaccinesinjapan
AT iwasakinagisa willingnesstopayforcovid19vaccinesinjapan
AT katsuyamahironobu willingnesstopayforcovid19vaccinesinjapan